DRREDDYBSEDR. REDDY S LABORATORIESMediumNegative
Announced Fri, 7 Aug · 23:05 IST

Dr Reddy's ends brand distribution pact with Novartis India

Major Contract CancelledBusiness Updates View source PDFExplain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.2%1-day move
₹1168.60
prior close
₹1172.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+0.2+0.1-0.3+3.2+2.3+3.3+2.7+2.0+0.1
Up moveDown movePending
AI summary

Dr Reddy's has terminated its February 11, 2022 agreement with Novartis India Limited for distribution and promotion of select brands in India. The termination follows a change in the controlling shareholding of Novartis India. The company will continue to commercialize the covered brands until September 30, 2026, after which the arrangement ends.

Likely market impact

Gradual wind-down with no immediate disruption, but revenue contribution from these Novartis brands in India will end after September 30, 2026.